FDA announces further plans to hasten digital health R&D

The FDA has announced further details about its plans to hasten development of digital health products and tools.

Pear Therapeutics in 2017 became the first company to get a “digital therapeutic” approved by the FDA, for patients trying to fight addiction to opioid drugs.